On Thursday, Bristol-Myers Squibb BMY will release its latest earnings report. Decipher the announcement with Benzinga's help.
Earnings and Revenue
Analysts expect Bristol-Myers Squibb earnings of 88 cents per share. Revenue will likely be around $5.44 billion, according to the consensus estimate.
In the same quarter last year, Bristol-Myers Squibb reported earnings per share of 74 cents on sales of $5.14 billion. If the company were to post earnings inline with the consensus estimate when it reports Thursday, EPS would be up 18.92 percent. Sales would be up 5.75 percent from the same quarter last year. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
EPS Estimate | 0.83 | 0.67 | 0.76 | 0.73 |
EPS Actual | 0.94 | 0.68 | 0.75 | 0.74 |
Stock Performance
Over the last 52-week period, shares of Bristol-Myers Squibb are up 4.69 percent. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The most common rating by analysts on Bristol-Myers Squibb stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Bristol-Myers Squibb is scheduled to hold a conference call at 10:30 a.m. ET and it can be accessed here: https://www.bms.com/investors.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.